Journal
CANCER AND METASTASIS REVIEWS
Volume 36, Issue 4, Pages 683-702Publisher
SPRINGER
DOI: 10.1007/s10555-017-9703-z
Keywords
E3 ligases; Ubiquitination; Cancer; E3-targeting compounds
Categories
Funding
- National Natural Sciences Foundation of China [81502065, 81672926]
- China Postdoctoral Science Foundation [2016T90613, 2015M580574, 2016M592146]
- Natural Sciences Foundation of Shandong Province [ZR2014HQ009]
- Shandong Postdoctoral Innovation Project [201602037]
- Qingdao Innovation Applied Basic Research Project [16-5-1-56-JCH]
- Qingdao Postdoctoral Research Project [2015167, 2015157]
Ask authors/readers for more resources
E3 ligases are a class of enzymes that can transfer ubiquitin to substrates for their degradation, which are of importance in cellular homeostasis. Since many oncogenic or tumor-suppressive proteins are reported to be regulated by the ubiquitin-proteasome system (UPS), E3 ligases, which function as substrate interacting modules, have been attracting more and more attention as promising anticancer drug targets due to their pivotal role in conferring substrate specificity. Generally, based on their molecular structure and functional mechanism, E3 ligases can be divided into three major types: homologous to E6-associated protein C-terminus (HECT), really interesting new gene (RING), and RING-in-between-RING (RBR) E3 ligases. Based on the significance of their functions, more bioactive compounds targeting E3 ligases should be developed in the future. In this review, we discuss the important roles of E3 ligases involved in cancer as well as available bioactive compounds targeting various E3 ligases for potential anticancer activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available